Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Titration of Polyprotic Acids with a Strong Base01:23

Titration of Polyprotic Acids with a Strong Base

2.4K
Titration of a polyprotic acid, which contains multiple ionizable protons, involves distinct dissociation steps, each with its own dissociation constant (Ka). Each successive Ka is weaker than the previous one. In the titration of a polyprotic acid like sulfurous acid with a strong base such as sodium hydroxide, the base first neutralizes the initial ionizable proton, forming an intermediate species (e.g., hydrogen sulfite ions). This step's titration curve resembles that of a weak...
2.4K
Titration of a Polyprotic Acid02:08

Titration of a Polyprotic Acid

98.1K
A polyprotic acid contains more than one ionizable hydrogen and undergoes a stepwise ionization process.  If the acid dissociation constants of the ionizable protons differ sufficiently from each other, then the titration curve for such polyprotic acid generates a distinct equivalence point for each of its ionizable hydrogens. Therefore, titration of a diprotic acid results in the formation of two equivalence points, whereas the titration of a triprotic acid results in the formation of three...
98.1K
Polyprotic Acids03:38

Polyprotic Acids

29.9K
Acids are classified by the number of protons per molecule that they can give up in a reaction. Acids such as HCl, HNO3, and HCN that contain one ionizable hydrogen atom in each molecule are called monoprotic acids. Their reactions with water are:
29.9K
Formation of Dilute Urine01:20

Formation of Dilute Urine

2.0K
The formation of dilute urine is a critical renal adaptation that maintains fluid balance, particularly during periods of high fluid intake. This process primarily involves the juxtamedullary nephrons. By adjusting the permeability of water and ions in response to physiological conditions, the kidneys can either conserve or excrete water, resulting in concentrated or dilute urine.
Filtrate Osmolarity in the PCT
Initially, as the filtrate passes through the proximal convoluted tubule (PCT), its...
2.0K
Renal Drug Excretion: Effect of Urine pH, Flow Rate, and Drug pKa01:22

Renal Drug Excretion: Effect of Urine pH, Flow Rate, and Drug pKa

330
The pH of urine, the drug's pKa, and the urine flow rate are vital parameters for drug reabsorption and excretion. Urinary pH varies between 4.6 and 8.0 and is influenced by diet, drug intake, and the patient's pathophysiology. It affects a drug's ionization state and reabsorption. For instance, carbohydrate-rich food produces alkaline urine promoting drug excretion, while proteins and certain medications like ascorbic acid lead to acidic urine enhancing reabsorption.
The pKa of a...
330
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

135
Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such...
135

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular profiling of chemotherapy-resistant breast cancer reveals DNA methylation remodeling associated with the acquisition of paclitaxel resistance.

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy·2026
Same author

Characterization of CTNND2-related neurodevelopmental disease, phenotype-genotype spectrum and WNT dynamics in early neurogenesis.

Research square·2026
Same author

[Frequency of hypogonadism and clinical features of systemic sclerosis and idiopathic inflammatory myopathies in men depending on testosterone levels].

Terapevticheskii arkhiv·2025
Same author

Placental mesenchymal stem cells: A promising platform for advancing gene therapy in pancreatic ductal adenocarcinoma.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2025
Same author

Magnetic Mesoporous Bioactive Glass Nanocomposite for Enhanced Osteogenesis and Angiogenesis in Bone Tissue Engineering.

ACS applied bio materials·2025
Same author

[Relationship between vitamin D and osteoarthritis].

Terapevticheskii arkhiv·2025
Same journal

Characterisation of the SMN1/2 locus using a highly specific variant caller on whole-genome sequence data from 500,000 individuals.

European journal of human genetics : EJHG·2026
Same journal

When truncation is not loss of function: neo-tail architecture as a determinant of pathogenicity in NMD-escaping frameshift variants.

European journal of human genetics : EJHG·2026
Same journal

CMIP as a novel candidate gene for neurodevelopmental and neuropsychiatric disorders.

European journal of human genetics : EJHG·2026
Same journal

Parent and professional experiences of a clinical trial of prenatal and postnatal stem cell therapy for severe osteogenesis imperfecta.

European journal of human genetics : EJHG·2026
Same journal

Scoping review and recommendations for development and delivery of education resources for reproductive genetic carrier screening.

European journal of human genetics : EJHG·2026
Same journal

Australian parents' perspectives on extended genomic screening: what information to return and when?

European journal of human genetics : EJHG·2026
See all related articles

Related Experiment Video

Updated: Oct 20, 2025

Assaying for Inorganic Polyphosphate in Bacteria
07:20

Assaying for Inorganic Polyphosphate in Bacteria

Published on: January 21, 2019

8.9K

Alkaptonuria in Russia.

Andrea Soltysova1,2, Alexandr Kuzin3,4, Elena Samarkina3

  • 1Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia.

European Journal of Human Genetics : EJHG
|September 10, 2021
PubMed
Summary
This summary is machine-generated.

Alkaptonuria (AKU) is a rare genetic disorder. This study identified 31 homogentisate 1,2-dioxygenase (HGD) gene variants in Russian AKU patients, with 14 being novel and exclusive to Russia.

More Related Videos

Removal of Arsenic Using a Cationic Polymer Gel Impregnated with Iron Hydroxide
08:01

Removal of Arsenic Using a Cationic Polymer Gel Impregnated with Iron Hydroxide

Published on: June 28, 2019

7.6K
Screening for Thermotoga maritima Membrane-Bound Pyrophosphatase Inhibitors
09:11

Screening for Thermotoga maritima Membrane-Bound Pyrophosphatase Inhibitors

Published on: November 23, 2019

6.8K

Related Experiment Videos

Last Updated: Oct 20, 2025

Assaying for Inorganic Polyphosphate in Bacteria
07:20

Assaying for Inorganic Polyphosphate in Bacteria

Published on: January 21, 2019

8.9K
Removal of Arsenic Using a Cationic Polymer Gel Impregnated with Iron Hydroxide
08:01

Removal of Arsenic Using a Cationic Polymer Gel Impregnated with Iron Hydroxide

Published on: June 28, 2019

7.6K
Screening for Thermotoga maritima Membrane-Bound Pyrophosphatase Inhibitors
09:11

Screening for Thermotoga maritima Membrane-Bound Pyrophosphatase Inhibitors

Published on: November 23, 2019

6.8K

Area of Science:

  • Genetics
  • Biochemistry
  • Rare Diseases

Background:

  • Alkaptonuria (AKU) results from homogentisic acid (HGA) accumulation.
  • Excess HGA forms ochronotic pigment, leading to connective tissue deposition and early-onset arthropathy.

Purpose of the Study:

  • To analyze the homogentisate 1,2-dioxygenase (HGD) gene variant spectrum in Russian Alkaptonuria (AKU) patients.
  • To identify novel HGD variants and characterize the genetic landscape of AKU in Russia.

Main Methods:

  • Sequencing of all 14 exons and flanking intronic regions of the HGD gene.
  • Multiplex Ligation-dependent Probe Amplification (MLPA) analysis.
  • Combined analysis of two Russian AKU cohorts (total 82 families).

Main Results:

  • Identified 31 distinct HGD variants in 82 Russian AKU families.
  • Discovered 14 novel HGD variants, previously unreported and found exclusively in Russia.
  • The c.481G>A (p.(Gly161Arg)) variant was the most prevalent, accounting for nearly 54% of AKU alleles in the cohort.

Conclusions:

  • The genetic spectrum of Alkaptonuria in Russia is diverse, with a significant number of novel and region-specific HGD variants.
  • Understanding the specific HGD variant landscape in different populations is crucial for accurate diagnosis and potential therapeutic strategies for AKU.
  • The high frequency of the c.481G>A variant highlights its importance in the Russian AKU population.